1958American Journal of Tropical Medicine and HygieneRequires access

Therapy of Trichuriasis and Ascariasis with Dithiazanine

J. C. Swartzwelder, Rachel Lampert, J. Houston Miller, Robert W. Sappenfield, William W. Frye, Stanley H. Abadie, Lisa Coco

Open publisher page 10 citations

Abstract

SummaryDithiasanine is an effective, oral, therapeutic agent for clinical and subclinical trichuriasis. This new anthelmintic is useful for mass therapy for trichuriasis. Since dithiazanine also has significant anthelmintic activity against A. lumbricoides, it is suitable for the treatment of mixed infections of trichuriasis and ascariasis, two helminthiases which frequently coexist in persons in endemic areas. An effective dosage of this drug for the therapy of trichuriasis and/or ascariasis is 20 mg per lb, with a maximum of 600 mg per day given in divided doses 3 times daily (i.e., 200 mg t.i.d.), for 5 or more days depending upon the size and severity of the infection. No serious side effects have occurred in several hundred children and adults treated with this anthelmintic.

About this research paper

What this paper is about

SummaryDithiasanine is an effective, oral, therapeutic agent for clinical and subclinical trichuriasis. This new anthelmintic is useful for mass therapy for trichuriasis. Since dithiazanine also has significant anthelmintic activity against A. lumbricoides, it is suitable for the treatment of mixed infections of trichuriasis and ascariasis, two helminthiases which frequently coexist in persons in endemic areas. An effective dosage of this drug for the therapy of trichuriasis and/or ascariasis is 20 mg per lb, with a maximum of 600 mg per day given in divided doses 3 times daily (i.e., 200 mg t.i.d.), for 5 or more days depending upon the size and severity of the infection. No serious side effects have occurred in several hundred children and adults treated with this anthelmintic.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SummaryDithiasanine is an effective, oral, therapeutic agent for clinical and subclinical trichuriasis. This new anthelmintic is useful for mass therapy for trichuriasis. Since dithiazanine also has significant anthelmintic activity against A. lumbricoides, it is suitable for the treatment of mixed infections of trichuriasis and ascariasis, two helminthiases which frequently coexist in persons in endemic areas. An effective dosage of this drug for the therapy of trichuriasis and/or ascariasis is 20 mg per lb, with a maximum of 600 mg per day given in divided doses 3 times daily (i.e., 200 mg t.i.d.), for 5 or more days depending upon the size and severity of the infection. No serious side effects have occurred in several hundred children and adults treated with this anthelmintic.

Key concepts: Trichuriasis, Anthelmintic, Ascariasis, Helminthiasis, Medicine, Pharmacotherapy, Subclinical infection, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapy of Trichuriasis and Ascariasis with Dithiazanine — Research Paper | ScholarLens